Minerva Neurosciences: 2Q Earnings Snapshot
Posted Aug 3, 2020 08:42:32 AM.
Last Updated Aug 3, 2020 08:54:26 AM.
WALTHAM, Mass. (AP) _ Minerva Neurosciences Inc. (NERV) on Monday reported second-quarter net income of $29.5 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Waltham, Massachusetts-based company said it had profit of 73 cents.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
The biotech drug developer posted revenue of $41.2 million in the period.
The company’s shares closed at $3.49. A year ago, they were trading at $6.65.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NERV at https://www.zacks.com/ap/NERV
The Associated Press
